Esperion Therapeutics develops drug treatment for syndromes of low levels of plasma high density lipoprotein (HDL)

History:

Esperion Therapeutics was acquired Pfizer at the end of 2003.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Midwest

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: